“…Endothelial cells undergoing the EndoMT can synthesize and secrete fibrogenic/inflammatory cytokines and produce excess ECM in fibrotic lesions, contributing to the development and progression of fibrosis in the lungs, liver, heart, dermis, cornea and kidneys 32 . Previous reports mention that some harmful stimulating factors, such as TGF-β1 33 , CTGF 34 , SiO 2 35 , serum response factor 36 , hypoxia 37 , can induce an EndoMT-like phenotype. In addition, recent research shows that under pathological conditions, cells undergoing the EndoMT can activate the transdifferentiation of neighboring cells via secretion of profibrotic cytokines in a paracrine-dependent manner 38 .…”